Clinical Trials
15 trialsNCT07616440 2026-06-04
Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Recruiting
NCT07589972 2026-05-15
Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase NA Not yet recruiting
NCT06386887 2026-05-07
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT07570368 2026-05-06
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
Universitas Airlangga
Phase NA Not yet recruiting
NCT07498959 2026-03-27
TESTIGO
Sahlgrenska University Hospital
Phase NA Recruiting
NCT03978663 2026-02-20
TRIO
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Active not recruiting
NCT07407244 2026-02-17
AKRA
Institute of Oncology Ljubljana
Phase NA Active not recruiting
NCT07413146 2026-02-17
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
Phase NA Not yet recruiting
NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT06739655 2026-02-04
PRADAIIBE
Cancer Research Antwerp
Phase NA Recruiting
NCT07038122 2025-12-18
RESET
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Active not recruiting
NCT07236320 2025-11-19
Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC
Sichuan Cancer Hospital and Research Institute
Phase NA Completed
NCT00462696 2025-10-06
ISNA-Sein
Institut Bergonié
Phase NA Completed
NCT07202819 2025-10-02
"NAC-MRI"
Assiut University
Phase NA Recruiting
NCT06876636 2025-07-29
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
Xijing Hospital
Phase NA Active not recruiting